The stock market is taking a breather after a relentless run, but opportunities still abound, according to some on Wall ...

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on 89bio (ETNB – Research Report) today and set a price target of $29.00. The ...

CJ Muse, Cantor Fitzgerald analyst, joins 'Squawk on the Street' to discuss the latest news regarding Qualcomm, if it's still ...

Cantor Fitzgerald lowered their FY2024 EPS estimates for shares of CVS Health in a report issued on Tuesday, December 31st.

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...

Cantor Fitzgerald’s price target would suggest a potential upside of 270.84% from the stock’s previous close. Other equities analysts also recently issued reports about the stock.

The Securities and Exchange Commission (SEC) on Thursday charged Cantor Fitzgerald L.P., a global financial services firm headed by one ...

Global Petroleum PLC has announced a change in its voting rights structure, with Cantor Fitzgerald Europe acquiring a significant stake. This acquisition raises Cantor Fitzgerald’s voting rights ...

Cantor Fitzgerald CEO Howard Lutnick is co-chair of the transition team for Donald Trump. The SEC says his firm caused two ...

Tether has made its first foray into venture capital by investing $2 million in Arcanum Capital’s Arcanum Emerging ...